Legal challenges aren’t slowing down the Trump administration’s push to reframe Medicaid as something closer to a welfare program.

Driving the news: The Centers for Medicare & Medicaid Services on Friday approved Ohio’s proposal to add work requirements to its Medicaid program.

  • Just a day earlier, Justice Department lawyers were back before the same federal judge who ruled against work requirements last year, urging him to let the policy move forward now.

The Trump administration is rolling out the policy specifics for a central promise in its plan to lower drug prices—taking on the system’s middlemen. Health and Human Services Secretary Alex Azar has long had his eye on pharmacy benefit managers (PBMs) and the rebates that are their bread and butter. The proposal HHS unveiled yesterday would essentially ban those rebates in Medicare and Medicaid, forcing PBMs to collect a flat fee for their work.

Many Democrats have embraced “Medicare for All,” but there’s a big variation in the policies they propose under that banner. This poll asked respondents two related questions—what they think candidates mean by “Medicare for All,” and what they want that policy to mean, if they support it at all. Overall, just 52% of those surveyed said they think “Medicare for All” refers to a single, government-run health care program covering everyone. Voters were more divided over what they want “Medicare for All” to be: 34% said they would favor a single-payer system; 33% said they would prefer an optional public plan alongside private insurance; 30% wanted neither. This poll shows that Medicare for All has different meanings to different people.

Many Republicans assume their party will take another stab at repealing and replacing the Affordable Care Act if the midterm elections go their way, even though GOP candidates aren’t making a big deal about it on the campaign trail.

Why it matters: Health care costs are one of the top issues voters say they care about, but any plan to address them would likely need to be bipartisan.

Show less

What to watch: The Senate health committee will begin a series of cost hearings this week. The House isn’t far behind, now that it has wrapped up a marathon of opioids bills.

. . .